| Schedule of carrying amount and financial information of equity-accounted investments |
| | | | | | | 2025 | | 2024 | Balance as of January 1 | | 7,087,142 | | — | Fair value of Neurosterix US Holdings LLC equity interest | | — | | 9,428,400 | Share of net loss of Neurosterix’s Group | | (4,012,443) | | (2,177,157) | Share of other comprehensive gain / (loss) of Neurosterix’s Group | | 773,097 | | (164,101) | Balance as of December 31 | | 3,847,796 | | 7,087,142 |
| | | | | | | December 31, 2025 | | December 31, 2024 | Current assets | | 24,419,137 | | 19,488,067 | Non-current assets | | 15,240,097 | | 15,054,727 | Current liabilities | | 2,491,407 | | 2,332,589 | Non-current liabilities | | 618,416 | | 709,052 | Net assets (100%) | | 36,549,411 | | 31,501,153 | Group share of net assets (20%) | | 7,309,882 | | 6,300,231 |
| | | | | | | 2025 | | 2024 | Income | | 105,460 | | 298,379 | Net loss for the period | | (20,037,010) | | (10,885,785) | Other comprehensive gain / (loss) | | 3,865,477 | | (820,507) | Total comprehensive loss | | (16,171,533) | | (11,706,292) |
|